Showing results (1991-2000 of 2,009) with videos related to

Sort By:
Pageof 201
Nature|August 14, 2023
Confirmation and refutation of very luminous galaxies in the early UniversePablo Arrabal Haro, Mark Dickinson, Steven L Finkelstein, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Physics in Medicine and Biology|May 8, 2020
Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directionsJan Schuemann, Alexander F Bagley, Ross Berbeco, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
JAMA Network Open|June 20, 2025
Percutaneous Nephrolithotomy vs Ureteroscopy for Kidney Stones in ChildrenJonathan S Ellison, David I Chu, Caleb P Nelson, et al.
JAMA Network Open|August 7, 2025
Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical TrialGregory E Tasian, David I Chu, Caleb P Nelson, et al.
The International Journal on Drug Policy|April 12, 2025
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trialLouisa Gilbert, Rouba Chahine, Redonna Chandler, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Pageof 201